Please login to the form below
mergers
This page shows the latest mergers news and features for those working in and with pharma, biotech and healthcare.
Healthcare PR agency Spink merges with emotive
Following the merger, Spink’s PR and public affairs expertise will become part of emotive’s medical and brand offering.
Latest news
-
Roche buys GenMark for $1.8bn to bolster diagnostics portfolio
Swiss pharma company Roche has entered into a definitive merger agreement to acquire GenMark Diagnostics for approximately $1.8bn.
-
FDA approves BMS’ blood cancer CAR T therapy after delay
BMS acquired Breyanzi following its $74bn takeover of Celgene in 2019 – the CAR-T therapy is one of the key assets critical to the potential payout of the merger in contingent ... As part of the merger agreement, BMS agreed to make a series of
-
Amgen strikes $240m autoimmune deal with Evoq Therapeutics
The divestiture of Otezla was a key antitrust requirement imposed by the Federal Trade Commission (FTC) on the BMS/Celgene merger.
-
Sanofi gains access to antibody tech with Kymab acquisition
With its significant global resources, we believe Sanofi is the perfect partner to progress Kymab’s pipeline of products and the merger will expedite the time it takes for our novel
-
FDA delays BMS’ liso-cel decision, citing COVID-19 travel restrictions
of the merger in contingent value rights (CVR). ... As part of the merger agreement, BMS agreed on a series of conditional payment to former Celgene shareholders or CVR holders, contingent on the regulatory approval of liso-cel by 31
More from news
Approximately 110 fully matching, plus 475 partially matching documents found.
Latest Intelligence
-
Integrating competitive intelligence into business development, licensing and M&A strategy
and mergers and acquisitions (M&A). ... One could think of larger companies as acquirers and smaller companies as acquirees in such transactions, but in many cases larger companies are acquired in mega-mergers, and small companies frequently
-
Transforming clinical trial data into a long-term asset
On the corporate side, it can come into play in licensing and partnership opportunities, in handling legal challenges and due diligence, and in mergers and acquisitions.
-
Sourcing R&D innovation: why pharma companies need to evolve their business models
the pipeline, the use of technology in medicine is expected to grow and so are the associated deals, mergers and acquisitions. ... They also can help identify collaboration opportunities including partnerships, licensing deals and merger or acquisition
-
Rebranding in an evolving world
It goes without saying that partnerships are a fundamental part of that portfolio expansion, which is why another key area of investment has been in mergers and acquisitions.
-
Pharma funding and M&A in 2020
Mega mergers. However, the flip side of new disruptors entering a sector is that the established players will of course seek to defend their positions. ... It’s unsurprising, therefore, that in recent years we’ve seen a number of mega mergers.
More from intelligence
Approximately 75 fully matching, plus 52 partially matching documents found.
Latest appointments
-
McCann Health North America appoints Jim Joseph as president
During his time serving as global president at BCW, he helped lead the complex merger of Burson Marsteller with Cohn &Wolfe.
-
New hires at Bayer, Eisai and Accord Healthcare
Marianne De Backer is a recognised business leader with an impressive track record spanning over two decades in research and commercial, as well as licensing, mergers and acquisitions,” said Stefan Oelrich,
-
Changes at Oxford PharmaGenesis, Reynolds-Mackenzie and more
2019 represents an exciting year for Reynolds-MacKenzie and Open Health, fuelled by the recent merger with Peloton Advantage in the US. I know Vicky will be a fantastic leader and
-
New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics
Cerato brings with him a wealth of business development experience, including in-licensing, out-licensing, alliance management, and mergers and acquisitions.
-
Ipsen bolsters leadership team
With expertise in corporate partnering, mergers and acquisitions, pipeline and product portfolio development, legal and IP strategy, Magovcevic-Liebisch has worked in several management roles including executive vice president and chief
More from appointments
Approximately 0 fully matching, plus 52 partially matching documents found.
Latest from PMHub
-
A MERGER THAT MATTERS
This is a merger that matters,” explains Ben. “It’s a genuine meeting of minds between three thriving agencies to help our clients realise their biggest ambitions.”.
-
Candice Subero to Lead Global Marketing for OPEN Health
With the merger of Pharmerit and Peloton Advantage, OPEN Health is a growing company that is shaping the healthcare industry.
-
Mergers and acquisitions: agents for change
How might your agency help? Every merger is unique, affecting brands, employees, and customers differently. ... Through experience Bedrock knows that during mergers and acquisitions, agencies can play an important role for clients.
-
How will the Tories’ historic win shape the NHS?
We also expect to see Clinical Commissioning Group (CCG) mergers continue apace.
-
Breaking Blue Research Joins Cello Health Insight
The merger brings specialist expertise that will strengthen our overall business insights and analytics offer by:. ... Managing Director Kate Andersen said: “The formal operational merger of these two companies is a natural next step for us.”.
More from PMHub
Approximately 1 fully matching, plus 15 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Account Management
-
Competitive Salary Offered
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Account Executive
-
Competitive Salary
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
-
Medical Editor
-
Competitive Salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
-
Associate Account Director
-
Competitive Salary
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
- Senior & Principal Medical Writer
-
Competitive Salary Offered
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
-
Publications Director
-
Competitive Salary
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Senior Medical Writer
-
Competitive Salary
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
-
Account Manager
-
Competitive Salary
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- GSK’s revenue drops by 18% in Q1 as performance pressures mount
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Single dose of COVID-19 vaccines ‘significantly’ reduces infections
- Novartis partners with Bill & Melinda Gates Foundation on ‘accessible’ sickle cell gene therapy
- Nanobiotechnology, Artificial Intelligence, and Virtual Care
- Virtual Trials, Remote Care, & Cross-Border Collaboration: Ethical & Legal Challenges
- Live Webinar: Blockchain in Healthcare: Predictions for the Post-COVID World
- Live Webinar: Digital Health for Improving Care in Disadvantaged Populations
- How can we strike the right balance between familiarity and innovation when it comes to data presentation?
- Illingworth Research Group wins ‘prestigious’ Queen’s Award
- Working in true partnership in a time of change
- Live Webinar: The Future of Digital Pills
- Total COVID-19 vaccine spending to reach $157bn by 2025, says report
- NICE sets out plans for ‘ambitious’ five-year strategy
- Pfizer CEO says oral COVID-19 pill could be ready by the end of the year
- PMEA 2021 has officially launched – with a new online entry system
PMHub
Empowering Strategic Performance Ltd
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...
Latest intelligence
- How can we strike the right balance between familiarity and innovation when it comes to data presentation?
- Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
- Deep 6 AI: the smart software breathing new life into clinical trials
- Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
- COVID-proof: How Teams are Creating Launch Intensity thru Adversity
- Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....
